These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34715973)

  • 1. Neuromuscular Blockade Monitoring and Reversal: A Clinical and Pharmacoeconomic Update.
    Weigel WA; Thilen SR
    Adv Anesth; 2021 Dec; 39():169-188. PubMed ID: 34715973
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular monitoring, reversal and postoperative residual neuromuscular block: An intradepartmental survey over the years.
    Cammu GV; Klewais LR; Vandeput DM; Foubert LA
    Anaesth Intensive Care; 2020 Jan; 48(1):73-75. PubMed ID: 31979984
    [No Abstract]   [Full Text] [Related]  

  • 3. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department.
    Todd MM; Hindman BJ; King BJ
    Anesth Analg; 2014 Aug; 119(2):323-331. PubMed ID: 24878683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Neuromuscular Blockade Reversal With Sugammadex After Vecuronium, Desflurane, and Magnesium Administration: A Case Report.
    Brown AF; Cobert J; Dierkes J; Kuhn CM; Grant SA
    A A Pract; 2019 Oct; 13(8):295-298. PubMed ID: 31283534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].
    Unterbuchner C; Ehehalt K; Graf B
    Anaesthesist; 2019 Nov; 68(11):744-754. PubMed ID: 31650189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
    Leonard PA; Todd MM
    A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative monitoring is inadequate for reliably determining full recovery from neuromuscular block whatever the protocol used.
    Hunter JM
    Br J Anaesth; 2018 Aug; 121(2):499-500. PubMed ID: 30032893
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
    de Boer HD; Carlos RV; Brull SJ
    BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Implementation of Quantitative Electromyographic Neuromuscular Monitoring in an Academic Anesthesia Department: Follow-Up Observations.
    Todd MM; Hindman BJ
    Anesth Analg; 2015 Sep; 121(3):836-838. PubMed ID: 26287308
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison between the flexor hallucis brevis and adductor pollicis muscles in atracurium-induced neuromuscular blockade using acceleromyography: A prospective observational study.
    Le Merrer M; Frasca D; Dupuis M; Debaene B; Boisson M
    Eur J Anaesthesiol; 2020 Jan; 37(1):38-43. PubMed ID: 31592900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause].
    Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H
    Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromuscular blockades. Agents, monitoring and antagonism].
    Schreiber JU; Fuchs-Buder T
    Anaesthesist; 2006 Nov; 55(11):1225-35; quiz 1236. PubMed ID: 17082884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
    Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasoning of an anomaly: residual block after sugammadex.
    Naguib M; Brull SJ; Arkes HR
    Anesth Analg; 2013 Aug; 117(2):297-300. PubMed ID: 23881373
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuromuscular Blockade Monitoring.
    Thilen SR; Weigel WA
    Anesthesiol Clin; 2021 Sep; 39(3):457-476. PubMed ID: 34392879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.